Gregory J. Metzger,Stephen C. Schmechel,Chaitanya Kalavagunta,Joseph S. Koopmeiners,Christopher A. Warlick
申请号：
US15089273
公开号：
US09858665B2
申请日:
2016.04.01
申请国别(地区):
US
年份:
2018
代理人:
摘要：
A user-independent, quantitative, multiparametric MRI model is developed and validated on co-registered correlative histopathology, yielding improved performance for cancer detection over single parameter estimators. A computing device may be configured to receive a first parametric map that maps imaged tissue of a patient using values of a first parameter, and a second parametric map that maps the imaged tissue using values of a second parameter, wherein the parametric maps are generated from medical imaging data for the imaged tissue. The computing device may be further configured to apply a multiparametric model to the maps to generate at least one Composite Biomarker Score for the tissue, the model being a function of the first parameter and the second parameter. The function may be determined based on co-registered histopathology data. The computing device may be further configured to generate an indication of whether the tissue includes predicted cancer, and output the indication.
